MindChild Medical, Inc. Their innovative technology platform, the MERIDIAN M110 non-invasive fetal electrocardiograph (fECG) monitor, is designed to provide obstetricians with comprehensive fetal heart rate data, comparable to the gold standard fetal scalp electrode. In addition, it offers novel ECG metrics, giving doctors a deeper understanding of fetal/maternal health and management.

MindChild was co-founded by Adam Wolfberg, MD, MFM, an Assistant Professor at Tufts Medical Center, and Gari Clifford, PhD, a Principal Research Scientist at Harvard-MIT Division of Health and Science Technology. The company has also partnered with E-TROLZ, Inc., a technology company focused on developing breakthrough physiologic monitoring platforms. With over 85% of live births in the US in 2011 requiring fetal monitoring, MindChild's technology addresses the limitations of current methods.

Their non-invasive approach minimizes the risk of maternal/fetal infection associated with fetal scalp electrodes, while enhancing the accuracy of fetal heart rate monitoring. MindChild Medical is dedicated to improving the safety and well-being of mothers and babies during labor and delivery